Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023
- Hoth Therapeutics, Inc. is set to present at the prestigious NobleCon 19th Annual Emerging Growth Investor Conference, providing an opportunity for the company to showcase its potential to a wider audience. This exposure could lead to increased investor interest and potential growth for the company.
- None.
NobleCon is the preeminent showcase of small and microcap companies
To learn more about NobleCon and registration to attend or scheduling a one-on-one meeting with management please visit https://noblecon19.com/#companies.
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit https://ir.hoththerapeutics.com/.
Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791
View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-to-present-at-noblecons-19th-annual-emerging-growth-investor-conference-december-3-5-2023-301984402.html
SOURCE Hoth Therapeutics, Inc.
FAQ
What is the company name and ticker symbol mentioned in the press release?
Where is the NobleCon 19th Annual Emerging Growth Investor Conference taking place?
Who is scheduled to present at the conference?
